Polar Capital Holdings PLC Intellia Therapeutics, Inc. Transaction History

Polar Capital Holdings PLC

  • $16.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$53.92 - $71.7 $13.6 Million - $18.1 Million
-252,785 Reduced 98.17%
4,725 $264,000
Q1 2022

May 16, 2022
BUY
$58.27 - $118.99 $15 Million - $30.6 Million
257,510 New
257,510 $18.7 Million
Q3 2021

Nov 15, 2021
SELL
$132.37 - $176.78 $12.5 Million - $16.7 Million
-94,624 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$60.88 - $161.91 $5.76 Million - $15.3 Million
94,624 New
94,624 $15.3 Million

Others Institutions Holding NTLA

# of Institutions
326
Shares Held
94.1M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $700M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Polar Capital Holdings PLC Portfolio

Follow Polar Capital Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email